Purchase this article with an account.
Vincent Nguyen, Umar Mian; Vitreoretinal Management in Proliferative Sickle Retinopathy Case Series in The Bronx. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1495.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To report the outcomes of surgical proliferative sickle retinopathy cases in the Bronx
The study is a retrospective, clinic-based study evaluating the outcomes . A series of patients from the retina department from 2013-2015 with multiple clinic locations throughout the Bronx was indentified using Montefiore's Clinical Looking Glass (CLG) to parse a computerized medical record system using ICD coding.
Results In a total of 43 proliferative sickle retinopathy patients' eyes, only 2 (4.7%) spontaneously regressed without treatment. 5 eyes (11.6%) underwent pars plana vitrectomies: 3 for vitreous hemorrhage, and 2 for tractional and/or rhegmatogenous retinal detachments, both which eventually failed and resulted in NLP vision. Most of these eyes improved to 20/50 vision with only one 20/200 eye. The rest of the non-surgical eyes were treated with retinopexy: 3 (7.0%) with barricaded retinal detachments, and the rest were treated successfully with scattered pan-retinal photocoagulation. Out of the 22 proliferative retinopathy patients, 8 have Hgb SS disease, while 14 have Hgb SC disease.
Most proliferative sickle retinopathy patients were adequately treated with scattered pan-retinal photocoagulation with good results in preserving visual acuity. Surgical management favored vitrectomies over scleral buckling. Patients who underwent vitrectomies for vitreous hemorrhage generally resulted in favorable outcomes, while those who underwent surgeries for retinal detachments generally had poorer prognosis.
This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.
This PDF is available to Subscribers Only